Treatment and Prognosis of 19 Patients with Duodenal Gastrointestinal Stromal Tumors

伍小军,万德森,方淯靖,陈功,李力人,卢震海,林俊忠,丁培荣,孔令亨,潘志忠
DOI: https://doi.org/10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2010.0140
2010-01-01
Abstract:Objective To analyze clinical characteristics and surgical treatment effects for the patients with duodenal gastrointestinal stromal tumors(GIST) and influential factors.Methods In the retrospective study,the clinical data and the tissue slices including immunohistochemical staining of 19 patients with duodenal GIST from January 1990 to October 2009 were rechecked,and all patients were followed up.SPSS 16.0 for windows software package was used for statistical analysis.The survival rate and related factors were analyzed in the two groups.Results Common lesions of duodenal GIST located in the descending and transverse portion.Common symptoms of duodenal GIST were alimentary tract hemorrhage.The overall survival rates at 1-,2-,and 5-year were 94.4%,77.3%,and 61.8%,respectively.The patients with tumor resected completely survival rates at 1-,2-,and 5-year were 100%,80.0%,and 80.0% but the patients with tumor resected incompletely were 80%,0%,and 0%.There was significant difference in survival rate between complete resection group and incomplete resection group(P0.05),but the significant difference was not detected between local resection and extended resection(P 0.05).Conclusion Surgery is still the main treatment for duodenal GIST.The surgical program is mainly determined by the location and size of tumor.Local complete resection is the principal treatment.Imatinib can improve the prognosis of the patients with duodenal GIST.
What problem does this paper attempt to address?